Proteins and phospholipids in BAL from patients with hydrostatic pulmonary edema

被引:60
作者
Nakos, G
Pneumatikos, J
Tsangaris, I
Tellis, C
Lekka, M
机构
[1] Intensive Care Unit, University Hospital of Ioannina, University of Ioannina, Ioannina
[2] Intensive Care Unit, University Hospital of Ioannina, 45500 Ioannina, University Street
关键词
D O I
10.1164/ajrccm.155.3.9117030
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
The purpose of the present study is twofold: to evaluate alterations in total phospholipid content and individual phospholipid classes of the surfactant, and to detect markers of inflammatory reaction in bronchoalveolar lavage (BAL) from patients with hydrostatic pulmonary edema (HPE). Mechanically ventilated patients with HPE (Group 1) were compared with mechanically ventilated patients without cardiopulmonary disease (Group 2), considered as the control group. Group 3, including patients with high-permeability pulmonary edema, was used for further comparison. BAL was obtained and immediately cooled at 4 degrees C. Total proteins, albumin, and platelet-activating factor-acetylhydrolase (PAF-AcH) were measured. Total lipids were extracted and analyzed after thin-layer chromatographic separation. PAF was determined with bioassay. Total BAL proteins and albumin were found significantly higher in patients with HPE compared with control, but were lower compared with adult respiratory distress syndrome (ARDS). PAF was elevated in patients with HPE and ARDS, whereas in the control group it was actually in nondetectable levels. PAF was significantly higher in ARDS than in HPE patients. BAL neutrophils concentration was higher in HPE compared with control, but lower compared with ARDS. There was an inverse correlation between PAF-AcH and PAF. Quantitative reduction of total BAL phospholipids (PL) and qualitative deficiency was observed in both patients with HPE and ARDS. The findings of this study suggest that there is evidence of inflammation in the airspaces of patients with HPE.
引用
收藏
页码:945 / 951
页数:7
相关论文
共 49 条
[1]   CATABOLISM OF PLATELET-ACTIVATING-FACTOR AND ITS ACYL ANALOG - DIFFERENTIATION OF THE ACTIVITIES OF LYSOPHOSPHOLIPASE AND PLATELET-ACTIVATING-FACTOR ACETYLHYDROLASE [J].
AARSMAN, AJ ;
NEYS, FW ;
VANDENBOSCH, H .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 1991, 200 (01) :187-193
[2]   EXPERIMENTAL HYDROSTATIC PULMONARY-EDEMA IN RABBIT LUNGS - BARRIER LESIONS [J].
BACHOFEN, H ;
SCHURCH, S ;
WEIBEL, ER .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1993, 147 (04) :997-1004
[3]   EFFECT OF PENTOXIFYLLINE ON THE INHIBITION OF SURFACTANT SYNTHESIS INDUCED BY TNF-ALPHA IN HUMAN TYPE-II PNEUMOCYTES [J].
BALIBREA CANTERO, JL ;
ARIASDIAZ, J ;
GARCIA, C ;
TORRESMELERO, J ;
SIMON, C ;
RODRIGUEZ, JM ;
VARA, E .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :699-706
[4]   PLATELET-ACTIVATING FACTOR AS A MEDIATOR OF ALLERGIC DISEASE [J].
BARNES, PJ ;
CHUNG, KF ;
PAGE, CP .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1988, 81 (05) :919-934
[5]  
BARTLETT GR, 1959, J BIOL CHEM, V234, P466
[6]   THE AMERICAN-EUROPEAN CONSENSUS CONFERENCE ON ARDS - DEFINITIONS, MECHANISMS, RELEVANT OUTCOMES, AND CLINICAL-TRIAL COORDINATION [J].
BERNARD, GR ;
ARTIGAS, A ;
BRIGHAM, KL ;
CARLET, J ;
FALKE, K ;
HUDSON, L ;
LAMY, M ;
LEGALL, JR ;
MORRIS, A ;
SPRAGG, R ;
COCHIN, B ;
LANKEN, PN ;
LEEPER, KV ;
MARINI, J ;
MURRAY, JF ;
OPPENHEIMER, L ;
PESENTI, A ;
REID, L ;
RINALDO, J ;
VILLAR, J ;
VANASBECK, BS ;
DHAINAUT, JF ;
MANCEBO, J ;
MATTHAY, M ;
MEYRICK, B ;
PAYEN, D ;
PERRET, C ;
FOWLER, AA ;
SCHALLER, MD ;
HUDSON, LD ;
HYERS, T ;
KNAUS, W ;
MATTHAY, R ;
PINSKY, M ;
BONE, RC ;
BOSKEN, C ;
JOHANSON, WG ;
LEWANDOWSKI, K ;
REPINE, J ;
RODRIGUEZROISIN, R ;
ROUSSOS, C ;
ANTONELLI, MA ;
BELOUCIF, S ;
BIHARI, D ;
BURCHARDI, H ;
LEMAIRE, F ;
MONTRAVERS, P ;
PETTY, TL ;
ROBOTHAM, J ;
ZAPOL, W .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1994, 149 (03) :818-824
[7]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[8]  
BOSSANT MJ, 1990, METHOD ENZYMOL, V187, P125
[9]   MICROVASCULAR MEMBRANE-PERMEABILITY IN HIGH SURFACE-TENSION PULMONARY-EDEMA [J].
BREDENBERG, CE ;
NIEMAN, GF ;
PASKANIK, AM ;
HART, AKE .
JOURNAL OF APPLIED PHYSIOLOGY, 1986, 60 (01) :253-259
[10]   NEUTROPHIL-ACTIVATING PEPTIDE-2 IN PATIENTS WITH PULMONARY-EDEMA FROM CONGESTIVE-HEART-FAILURE OR ARDS [J].
COHEN, AB ;
STEVENS, MD ;
MILLER, EJ ;
ATKINSON, MAL ;
MULLENBACH, G ;
MAUNDER, RJ ;
MARTIN, TR ;
WIENERKRONISH, JP ;
MATTHAY, MA .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 264 (05) :L490-L495